“Polymeric Nanoparticle-Mediated Delivery of Oncolytic Measles Virus for Targeted Therapy in Cervical Cancer”. 2024. Pharmaceutical Communications 3 (1): 45-53. https://doi.org/10.55627/pharma.003.001.0887.